Journal of Lipid Research, Vol 27, 1124-1134, Copyright © 1986 by Lipid Research, Inc.

ARTICLES

A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non- scavenger-receptor mechanism

RE Morton, GA West and HF Hoff

A lipoprotein particle designated A-LDL, which contains apolipoprotein B (apoB) and which is the size of plasma low density lipoproteins (LDL), was isolated from homogenates of human aortic athersclerotic plaques by a combination of affinity chromatography and gel-filtration. Compared to plasma LDL, A-LDL was more electronegative, its hydrated density was lower and more heterogeneous, and its protein-to-lipid ratio was lower. In addition, apoB in A-LDL was highly degraded, and A- LDL was recognized by mouse peritoneal macrophages (MPM) as indicated by its ability to stimulate cholesterol esterification. Cholesterol esterification was saturable with an apparent Km of 100 micrograms of A- LDL cholesterol/ml. Stimulation of cholesterol esterification was linear with time, leading to extensive accumulation of cholesteryl ester in MPM over a 48-hr time interval. The uptake or degradation of acetyl-LDL (radiolabeled either in the protein with 125I or hydrophobic core with [3H]cholesteryl ether) was markedly decreased by excess unlabeled acetyl-LDL but not by A-LDL, and excess acetyl-LDL did not inhibit the uptake or degradation of labeled A-LDL. However, a 10-fold excess of A-LDL also failed to inhibit the uptake of labeled A-LDL. This finding was consistent with the observation that, unlike the saturable stimulation of cholesterol esterification in MPM induced by A- LDL, the uptake of cholesteryl ether-labeled A-LDL was almost linear over a 0-400 micrograms cholesterol/ml range. This discrepancy between dose response curves for A-LDL, which did not occur for acetyl-LDL, could be eliminated by a 24-hr postincubation period in the absence of lipoprotein, suggesting that A-LDL is catabolized less efficiently than acetyl-LDL following internalization. In summary, we conclude that A- LDL uptake by MPM occurs via a low affinity-high capacity process. Although the uptake of A-LDL is not readily saturated, it is of sufficient affinity to lead to lipid loading of macrophages even when A- LDL is present at relatively low concentrations. If these mechanisms are operative in vivo, they could explain how foam cells in human fatty streak lesions develop.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. SANTANAM, A. A. MURPHY, and S. PARTHASARATHY Macrophages, Oxidation, and Endometriosis Ann. N.Y. Acad. Sci., March 1, 2002; 955(1): 183 - 198. [Abstract] [Full Text] [PDF]

				V. Llorente-Cortes, J. Martinez-Gonzalez, and L. Badimon LDL Receptor-Related Protein Mediates Uptake of Aggregated LDL in Human Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1572 - 1579. [Abstract] [Full Text] [PDF]

				L. Kritharides, J. Upston, W. Jessup, and R. T. Dean Accumulation and metabolism of low density lipoprotein-derived cholesteryl linoleate hydroperoxide and hydroxide by macrophages J. Lipid Res., December 1, 1998; 39(12): 2394 - 2405. [Abstract] [Full Text]

				S. Chatterjee Sphingolipids in Atherosclerosis and Vascular Biology Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1523 - 1533. [Abstract] [Full Text] [PDF]

				I. Maor, T. Hayek, R. Coleman, and M. Aviram Plasma LDL Oxidation Leads to Its Aggregation in the Atherosclerotic Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2995 - 3005. [Abstract] [Full Text]

				R. E. Morton and D. J. Greene Suppression of Lipid Transfer Inhibitor Protein Activity by Oleate : A Novel Mechanism of Cholesteryl Ester Transfer Protein Regulation by Plasma Free Fatty Acids Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3041 - 3048. [Abstract] [Full Text]

				P. Fox and P. DiCorleto Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein Science, July 22, 1988; 241(4864): 453 - 456. [Abstract] [PDF]